The historical rank and industry rank for Biora Therapeutics's Equity-to-Asset or its related term are showing as below:
BIOR'
s Equity-to-Asset Range Over the Past 10 Years
Min: -3.25 Med: -0.8 Max: -0.32
Current: -3.25
During the past 6 years, the highest Equity to Asset Ratio of Biora Therapeutics was -0.32. The lowest was -3.25. And the median was -0.80.
BIOR's Equity-to-Asset is ranked worse than 95.34% of 1565
companies
in the Biotechnology industry
Industry Median: 0.67
vs BIOR: -3.25
Biora Therapeutics Equity-to-Asset Historical Data
The historical data trend for Biora Therapeutics's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Biora Therapeutics's Equity-to-Asset
For the Biotechnology subindustry, Biora Therapeutics's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biora Therapeutics's Equity-to-Asset Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Biora Therapeutics's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Biora Therapeutics's Equity-to-Asset falls into.
Biora Therapeutics Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Biora Therapeutics's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Biora Therapeutics Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Biora Therapeutics's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Biora Therapeutics (Biora Therapeutics) Business Description
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology. Geographically, it operates only in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BIOR has been successfully added to your 